DTC Brief Summary: Consumers Prefer Q&A Format, Researcher Tells FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
University of Georgia professor says consumers reacted negatively to use of a prominent risk information window in print ads. FDA ad division official questions whether a drug’s efficacy information should be included in the brief summary.